Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000505498 | SCV000940586 | uncertain significance | Deficiency of acetyl-CoA acetyltransferase | 2021-09-02 | criteria provided, single submitter | clinical testing | This sequence change replaces histidine with arginine at codon 400 of the ACAT1 protein (p.His400Arg). The histidine residue is highly conserved and there is a small physicochemical difference between histidine and arginine. This variant is present in population databases (rs761086326, ExAC 0.01%). This variant has not been reported in the literature in individuals affected with ACAT1-related conditions. ClinVar contains an entry for this variant (Variation ID: 438580). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Possibly Damaging"; Align-GVGD: "Class C0"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Foundation for Research in Genetics and Endocrinology, |
RCV000505498 | SCV000599597 | likely pathogenic | Deficiency of acetyl-CoA acetyltransferase | 2017-09-11 | no assertion criteria provided | clinical testing | The variant c.1199A>G(p.H400R) is not reported in 1000 genomes database and has minor allele frequency of 0.0016% in ExAC database. The in silico prediction of this variant is damaging by LRT, PolyPhen, SIFT and MutationTaster. |
Natera, |
RCV000505498 | SCV002090077 | uncertain significance | Deficiency of acetyl-CoA acetyltransferase | 2021-01-27 | no assertion criteria provided | clinical testing |